The Synergistic Anticancer Effect of Pitavastatin and Metformin Against BT-20 Breast Cancer Cell Line Types
Israa University Journal for Applied Science · 2025
DOI: 10.52865/fbtv6754 ↗Kurz gefasst
Fachartikel in der Zeitschrift Israa University Journal for Applied Science, 2025. Verfasst von Nader N. Alnahhal und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Breast cancer ranks second in terms of all malignancies worldwide, making it one of the most common cancers. Treatment efforts for breast cancer have several disadvantages, including cytotoxic side effects and multidrug resistance. As a result, a shift toward more effective drugs with fewer side effects is required. Studies have recently demonstrated the efficacy of both Pitavastatin and Metformin against cancer cells, and we found that their combination has a significant influence against breast cancer cells when compared to utilizing either drug alone.
Methods
The cytotoxicity of Metformin and Pitavastatin on BT-20 breast cancer cells was evaluated using the MTT test. A trypan blue assay was used to evaluate the combined treatment's anti-proliferative effects.
Results
According to the study's findings, BT-20 cell viability was decreased by pitavastatin and metformin treatments alone in a concentration- and time-dependent manner. However, combining the two drugs resulted in a greater antiproliferative impact on BT-20 cells. Trypan blue results showed that combination drugs kill BT-20 cells more than single treatments.
Conclusion
The results suggest that the combination of Pitavastatin and Metformin has a synergistic anticancer effect against BT-20 breast cancer cells.
Zitieren
APA
Alnahhal, N. N., Adris, M. A., Aliwaini, S. H., & Altaher, A. M. (2025). The Synergistic Anticancer Effect of Pitavastatin and Metformin Against BT-20 Breast Cancer Cell Line Types. Israa University Journal for Applied Science. https://doi.org/10.52865/fbtv6754
Vancouver
Alnahhal NN, Adris MA, Aliwaini SH, Altaher AM. The Synergistic Anticancer Effect of Pitavastatin and Metformin Against BT-20 Breast Cancer Cell Line Types. Israa University Journal for Applied Science. 2025. doi:10.52865/fbtv6754
BibTeX
@article{Alnahhal2025,
author = {Alnahhal, Nader N. and Adris, Mohammed A. and Aliwaini, Saeb H. and Altaher, Akram M.},
title = {The Synergistic Anticancer Effect of Pitavastatin and Metformin Against BT-20 Breast Cancer Cell Line Types},
journal = {Israa University Journal for Applied Science},
year = {2025},
doi = {10.52865/fbtv6754}
}
EUVIMED